Target intelligence / Profile preview

Blood Plasma Volume Expansion via Replacement of Albumin and Globulins (PVE (Albumin/Globulin))

Target
PVE (Albumin/Globulin)
Molecular classification
Physiological Process, Therapeutic Intervention
01

Overview

Blood plasma volume expansion through the replacement of albumin and globulins is a therapeutic strategy used to increase the intravascular fluid volume. This is achieved by supplementing or replacing key plasma proteins, primarily albumin and globulins, which are responsible for maintaining colloid osmotic pressure. The increased oncotic pressure draws fluid from interstitial spaces into the bloodstream, effectively expanding blood plasma volume. While beneficial in treating hypovolemia and supporting procedures like plasmapheresis, careful monitoring is essential to avoid complications such as fluid overload and dilution of other vital plasma components.

Other names
Plasma Volume ExpansionAlbumin Replacement TherapyGlobulin Replacement TherapyColloid Osmotic Pressure EnhancementIntravascular Volume Augmentation
02

Mechanism of action

Increases colloid osmotic/oncotic pressure, drawing fluid into vasculature and expanding plasma volume.

03

Biological functions

Regulation of blood volumeMaintenance of oncotic pressureFluid homeostasisCirculatory support
04

Disease associations

HypovolemiaHypoalbuminemiaShockBurnsNephrotic SyndromeLiver FailureHemorrhage
05

Safety considerations

Fluid OverloadPulmonary EdemaAllergic Reactions (to albumin/globulin)Dilutional CoagulopathyTransfusion-Related Acute Lung Injury (TRALI)Transfusion-Associated Circulatory Overload (TACO)Infection Transmission (rare)Potential dilution/loss of other proteins if not comprehensively replaced during plasma exchange
06

Interacting drugs

Human Serum Albumin

3 more in the full profile.

07

Biomarkers

Serum Albumin LevelsTotal Protein LevelsOncotic PressureBlood PressureUrine OutputCentral Venous Pressure (CVP)

Beyond the preview

Go deeper on Blood Plasma Volume Expansion via Replacement of Albumin and Globulins (PVE (Albumin/Globulin)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood Plasma Volume Expansion via Replacement of Albumin and Globulins (PVE (Albumin/Globulin)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call